Short Interest in PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Declines By 81.4%

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totaling 17,878 shares, a decrease of 81.4% from the August 15th total of 95,953 shares. Based on an average trading volume of 345,630 shares, the short-interest ratio is presently 0.1 days.

PharmaTher Stock Performance

PharmaTher stock opened at $0.04 on Friday. The firm’s 50-day moving average is $0.04 and its 200-day moving average is $0.05. PharmaTher has a 1 year low of $0.03 and a 1 year high of $0.30.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.